Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Pulmonary Circulation|July 7, 2022
Differentiating pulmonary hypertension associated with protein kinase inhibitorsJoshua A Jacobs, Eiman Jahangir, John J Ryan
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|May 5, 2017
Temperature Instability in an Infant Treated with Propranolol for Infantile HemangiomaBetsy Walters Burkey, Joshua A Jacobs, Hany Aziz
Journal of Clinical Hypertension (Greenwich, Conn.)|September 14, 2024
Lipoprotein(a) among normotensive patients and risk of incident hypertensionAlexander R Zheutlin, Joshua A Jacobs, Brian Stamm, et al.
Pharmacotherapy|January 20, 2025
Prevalence of prescription medication use that can exacerbate heart failure among US adults with heart failureAlexander R Zheutlin, Joshua A Jacobs, Joshua D Niforatos, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 26, 2018
Outcomes for Cancer Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionJoshua A Jacobs, Kerry Pickworth, Konstantinos Dean Boudoulas, et al.
The Annals of Pharmacotherapy|January 16, 2023
Evaluation of Safety and Efficacy of Intravenous Digoxin Loading Doses Based on Ideal Body WeightJessi L Clark, Joshua A Jacobs, Alexandre H Watanabe, et al.
Journal of Cardiac Failure|June 10, 2022
Metolazone Versus Intravenous Chlorothiazide for Decompensated Heart Failure Sequential Nephron Blockade: A Retrospective Cohort StudyTamara Cisowska, Irene Z Pan, Joseph Biskupiak, et al.
Clinics in Geriatric Medicine|September 30, 2024
Pharmacologic Treatment of Hypertension in Older AdultsOliver M Todd, Matthew Knight, Joshua A Jacobs, et al.
Journal of Clinical Lipidology|August 20, 2023
Age-based disparities in statin use for primary prevention in US adults: National Health and Nutrition Examination Surveys 2013-2020Alexander R Zheutlin, Joshua A Jacobs, Catherine G Derington, et al.
American Journal of Preventive Cardiology|December 21, 2023
Glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter 2 inhibitor use among adults with diabetes mellitus by cardiovascular-kidney disease risk: National Health and Nutrition Examination Surveys, 2015-2020Joshua A Jacobs, Alexander R Zheutlin, Catherine G Derington, et al.
Pageof 4